This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various therapeutic agents. Its unique spirocyclic structure makes it valuable for developing drugs that target neurological disorders, particularly those involving the central nervous system. Researchers have explored its potential in creating compounds that modulate neurotransmitter activity, which could be beneficial in treating conditions like anxiety, depression, and epilepsy. Additionally, its structural features are being investigated for their role in enhancing the bioavailability and stability of drug molecules, making it a promising candidate for improving drug delivery systems.